Literature DB >> 15698730

Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy.

D M Kecmanovic1, M J Pavlov, M S Ceranic, A V Sepetkovski, P A Kovacevic, A B Stamenkovic.   

Abstract

PURPOSE: Peritoneal carcinomatosis from colorectal cancer is resistant to standard treatments and median survival time for patients ranges between 6 and 8 months. Aggressive cytoreductive surgery with hyperthermic intraperitoneal perioperative chemotherapy may increase median survival.
METHOD: Patients undergoing cytoreductive surgery and perioperative hyperthermic chemotherapy (mitomycin C, intraoperatively; 5-fluorouracil early post-operatively) for peritoneal carcinomatosis from colorectal cancer from 1996 to 2003 were evaluated retrospectively.
RESULTS: From 1996 to 2003, 18 cytoreductive procedures were performed. The post-operative morbidity rate was 44.4% with no treatment related mortality. The median total operation time was 5 h 28 min (range: 3 h 20 min to 7 h 10 min). The median follow-up was 21 months. The median survival was 15 months.
CONCLUSION: Surgical debulking and perioperative intraperitoneal chemotherapy improved survival with acceptable morbidity and mortality. Completeness of the resection was the most important prognostic indicator.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15698730     DOI: 10.1016/j.ejso.2004.09.021

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  23 in total

1.  Peritoneal carcinomatosis of colorectal origin: standard of care.

Authors:  Tristan D Yan
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

Review 2.  Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

Authors:  Manuel J Koppe; Otto C Boerman; Wim J G Oyen; Robert P Bleichrodt
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

Review 3.  Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.

Authors:  Hassan-Alaa-Hammed Al-Shammaa; Yan Li; Yutaka Yonemura
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

4.  Cytoreductive surgery combined with intraperitoneal chemohyperthermia for the treatment of advanced colon cancer.

Authors:  Claudio Zanon; Massimiliano Bortolini; Isabella Chiappino; Paolo Simone; Francesco Bruno; Piero Gaglia; Mario Airoldi; Leonorda Deriu; Alon Mashiah
Journal:  World J Surg       Date:  2006-11       Impact factor: 3.352

5.  Clinical benefit of surgery for stage IV colorectal cancer with synchronous peritoneal metastasis.

Authors:  Hirotoshi Kobayashi; Kenjiro Kotake; Kimihiko Funahashi; Kazuo Hase; Koichi Hirata; Tsuneo Iiai; Shingo Kameoka; Yukihide Kanemitsu; Koutarou Maeda; Akihiko Murata; Masayuki Ohue; Kazuo Shirouzu; Keiichi Takahashi; Toshiaki Watanabe; Hideaki Yano; Toshimasa Yatsuoka; Yojiro Hashiguchi; Kenichi Sugihara
Journal:  J Gastroenterol       Date:  2013-06-24       Impact factor: 7.527

Review 6.  Treatment recommendations for metastatic colorectal cancer.

Authors:  Enrique Aranda; Albert Abad; Alfredo Carrato; Andrés Cervantes; Jesús García-Foncillas; Pilar García Alfonso; Rocío García Carbonero; Auxiliadora Gómez España; Josep M Tabernero; Eduardo Díaz-Rubio
Journal:  Clin Transl Oncol       Date:  2011-03       Impact factor: 3.405

7.  [Peritoneal carcinomatosis. Surgical treatment, including hyperthermal intraperitoneal chemotherapy].

Authors:  G Glockzin; N Ghali; S A Lang; A Agha; H J Schlitt; P Piso
Journal:  Chirurg       Date:  2007-12       Impact factor: 0.955

8.  Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerations.

Authors:  Ning Miao; James F Pingpank; H Richard Alexander; Richard Royal; Seth M Steinberg; Martha M Quezado; Tatiana Beresnev; Zenaide M N Quezado
Journal:  Ann Surg Oncol       Date:  2008-12-03       Impact factor: 5.344

9.  Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies.

Authors:  P Piso; M H Dahlke; N Ghali; I Iesalnieks; M Loss; F Popp; P von Breitenbuch; A Agha; S A Lang; F Kullmann; H J Schlitt
Journal:  Int J Colorectal Dis       Date:  2007-04-26       Impact factor: 2.571

10.  A critical evaluation of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis.

Authors:  Akshat Saxena; Tristan D Yan; David L Morris
Journal:  World J Surg       Date:  2010-01       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.